{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:04:54Z","timestamp":1790053494316,"version":"4.0.1"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperinflammatory disorder often driven by primary immunodeficiencies like X-linked lymphoproliferative syndrome (XLP) in infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case description<\/jats:title>\n                    <jats:p>\n                      We report a 2-month-old male with primary immunodeficiency who developed HLH triggered by cytomegalovirus (CMV), confirmed via bone marrow PCR and hemophagocytosis findings. Initial immunophenotyping during acute hyperinflammation showed marked secondary disruptions across lymphocyte subpopulations, including severe lymphopenia in CD4+ T cells and pre-germinal center B cells. Genetic sequencing identified a pathogenic hemizygous variant in the\n                      <jats:italic>XIAP\/BIRC4<\/jats:italic>\n                      gene, confirming X-linked lymphoproliferative syndrome type 2 (XLP-2). The patient was managed with the HLH-2004 protocol, valganciclovir, immunoglobulins, and transfusions, complicated by severe pancytopenia.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This case demonstrates an atypical XLP-2 presentation where CMV, rather than Epstein-Barr virus, triggered HLH. Following stabilization and viral clearance, the patient successfully underwent allogeneic hematopoietic stem cell transplantation (HSCT) from a matched family donor. On day +30 post-HSCT, molecular chimerism confirmed 97.87% donor engraftment. On day +39 post-HSCT, the infant is clinically stable, actively recovering at last assessment from grade II cutaneous graft-versus-host disease (GvHD) under immunosuppression, with low-level CMV viral reactivation (951 copies\/mL) managed under close surveillance. At the comprehensive 9-month follow-up from initial presentation, the patient maintained overall systemic stability without evidence of disease relapse or secondary organ dysfunction, highlighting the necessity of long-term monitoring in post-transplant cGvHD management, and proving the life-saving role of early genetic diagnosis and timely HSCT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1940119","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:25:27Z","timestamp":1790051127000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Hemophagocytic lymphohistiocytosis in an infant associated with cytomegalovirus infection and X-linked primary immunodeficiency"],"prefix":"10.3389","volume":"17","author":[{"given":"Xavier","family":"Garc\u00eda-Leon","sequence":"first","affiliation":[{"name":"Departamento de Biolog\u00eda Celular e Histolog\u00eda, Facultad de Medicina, Universidad Complutense de Madrid","place":["Madrid, Spain"]},{"name":"Dr. Juan Tanca Marengo National Oncological Hospital- Sociedad de Lucha Contra el Cancer del Ecuador (SOLCA) Guayaquil","place":["Samborond\u00f3n, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"G\u00f3mez del Moral","sequence":"additional","affiliation":[{"name":"Departamento de Biolog\u00eda Celular e Histolog\u00eda, Facultad de Medicina, Universidad Complutense de Madrid","place":["Madrid, Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Ramirez-Velasategui","sequence":"additional","affiliation":[{"name":"Centro de Salud Lojas-Daule","place":["Daule, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy Mariuxi","family":"Illescas-Romero","sequence":"additional","affiliation":[{"name":"Centro de Salud Yatubi-Bolivar","place":["Bolivar, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Ram\u00f3n","family":"G\u00f3mez-Garc\u00eda","sequence":"additional","affiliation":[{"name":"Escuela de Posgrado en Salud, Universidad Esp\u00edritu Santo, Samborond\u00f3n","place":["Samborond\u00f3n, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago J.","family":"Ballaz","sequence":"additional","affiliation":[{"name":"Centro de Investigaci\u00f3n Biom\u00e9dica (CENBIO), Facultad de Ciencias de la Salud Eugenio Espejo, Universidad UTE","place":["Quito, Ecuador"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.21037\/aob-25-3","article-title":"Hemophagocytic lymphohistiocytosis (HLH): a narrative review of the pathogenesis, clinical presentation, diagnosis, treatment, and prognosis","volume":"10","author":"Toumeh","year":"2025","journal-title":"Ann Blood"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH\u20102004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2314005","article-title":"Hemophagocytic lymphohistiocytosis","volume":"392","author":"Henter","year":"2025","journal-title":"New Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3892\/etm.2023.12122","article-title":"Secondary hemophagocytic lymphohistiocytosis in children: pathophysiology, diagnosis and treatment","volume":"26","author":"Benevenuta","year":"2023","journal-title":"Exp Ther Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1620327","article-title":"X-linked lymphoproliferative disease type 1: a clinical and genetic update","volume":"16","author":"Li","year":"2025","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.62703","article-title":"XIAP deficiency complicated by HLH on immunotherapy","volume":"16","author":"Kim","year":"2024","journal-title":"Cureus"},{"key":"B7","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.clicom.2023.02.008","article-title":"X-linked inhibitor of apoptosis (XIAP) deficiency presenting as HLH triggered by drug allergy","volume":"3","author":"Khojah","year":"2023","journal-title":"Clin Immunol Commun"},{"key":"B8","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13045-024-01621-x","article-title":"Hemophagocytic lymphohistiocytosis: current treatment advances and emerging targeted therapy","volume":"17","author":"Wu","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023707","article-title":"IL-1\u2013mediated hyperinflammation in XIAP deficiency linked to defective autophagy","volume":"144","author":"Dissanayake","year":"2024","journal-title":"Blood"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2025.2503745","article-title":"Epstein\u2013Barr virus infection plays a crucial role in triggering hemophagocytic lymphohistiocytosis in patients with XIAP deficiency","volume":"30","author":"Shi","year":"2025","journal-title":"Hematology"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.70165\/cglobal.v9i2.425","article-title":"Impacto de la determinaci\u00f3n de subpoblaciones linfocitarias en el pron\u00f3stico y respuesta al tratamiento en pacientes con inmunodeficiencias primarias","volume":"9","author":"Barona Velasco","year":"2024","journal-title":"Conocimiento Global"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-031-59815-9_15","article-title":"Infectious triggers of cytokine storm syndromes: herpes virus family (non-EBV)","volume":"1448","author":"Dulek","year":"2024","journal-title":"Adv Exp Med Biol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/6964818","article-title":"Cytomegalovirus-induced HLH in an immunocompromised patient with inflammatory bowel disease","volume":"2024","author":"Pedicelli","year":"2024","journal-title":"Case Rep Hematol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2024.286477","article-title":"Histiocyte Society blueprint for hemophagocytic lymphohistiocytosis research: deciphering underlying disease mechanisms to optimize diagnosis and therapy","volume":"110","author":"Meyer","year":"2025","journal-title":"Haematologica"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2021.660520","article-title":"Evolution of our understanding of XIAP deficiency","volume":"9","author":"Mudde","year":"2021","journal-title":"Front Pediatr"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01621-x","article-title":"Hemophagocytic lymphohistiocytosis: current treatment strategies and emerging therapies","volume":"15","author":"Wu","year":"2024","journal-title":"Front Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00246","article-title":"The EuroFlow PID Orientation Tube for flow cytometric diagnostic screening of primary immunodeficiencies of the lymphoid system","volume":"10","author":"Van der Burg","year":"2019","journal-title":"Front Immunol"},{"key":"B18","first-page":"S1","article-title":"Diagnostic criteria for primary immunodeficiencies","volume":"19","year":"1999","journal-title":"J ClinImmunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s12016-025-09068-9","article-title":"Promising targeted therapies for hemophagocytic lymphohistiocytosis: a translational perspective based on immunopathology","volume":"68","author":"Yang","year":"2025","journal-title":"Clin Rev Allerg Immunolol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1163316","article-title":"The hyperinflammatory spectrum: from defects in cytotoxicity to cytokine control","volume":"14","author":"Planas","year":"2023","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1678233","article-title":"Flow cytometric analysis of immune subsets in adult HLH","volume":"16","author":"Qin","year":"2025","journal-title":"Front Immunol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-07-298372","article-title":"Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1\/SAP deficiency) versus type 2 (XLP-2\/XIAP deficiency)","volume":"117","author":"Pachlopnik Schmid","year":"2011","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/cei.12284","article-title":"A new functional assay for the diagnosis of X-linked inhibitor of apoptosis (XIAP) deficiency","volume":"176","author":"Ammann","year":"2014","journal-title":"Clin Exp Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-024-01182-6","article-title":"Immunopathology of and potential therapeutics for secondary HLH\/MAS: a translational perspective","volume":"56","author":"Nguyen","year":"2024","journal-title":"Exp Mol Med"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1940119\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T04:25:27Z","timestamp":1790051127000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1940119\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":24,"alternative-id":["10.3389\/fimmu.2026.1940119"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1940119","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1940119"}}